Metabolomic Discoveries for Traditional Chinese Medicine Efficacy in Alzheimer′s Disease
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/2455800 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioMed Research International, online erschienen am 31.07.2026. Verfasst von Huimin Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China, glyy.org. Hauptthemen laut MEDLINE: Alzheimer Disease, Medicine, Chinese Traditional, Metabolomics, Drugs, Chinese Herbal. Die Arbeit nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen, The National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer′s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and behavioral alterations. However, the complex etiology and pathogenesis of AD have thus far precluded the development of satisfactory therapeutic agents. Traditional Chinese medicine (TCM) has garnered increasing recognition for its potential in AD management due to its multicomponent, multitarget therapeutic strategy. Metabolomics, an advanced analytical methodology for investigating metabolic alterations in biological systems, has yielded significant insights into both the therapeutic efficacy and mechanistic underpinnings of TCM interventions for AD. This review synthesizes recent metabolomic findings associated with TCM approaches to AD treatment, identifying key metabolic pathways across diverse biological specimens, including brain tissue, blood, urine, and feces. Through systematic elucidation of these metabolic networks, metabolomics offers substantial potential to facilitate the advancement of TCM‐derived therapeutics for AD, potentially enhancing global patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China, glyy.org.
- Department of Respiratory Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China, glyy.org.
- Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, Shenzhen, Guangdong, China, glyy.org.
ORCID-Profile: Huimin Sun, Pengfei Zhang, Changchun Zeng
Förderung
- Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen
- The National Natural Science Foundation of China
Zitieren
APA
Sun, H., Huang, D., Yang, F., Zhang, P., Yang, D., & Zeng, C. (2026). Metabolomic Discoveries for Traditional Chinese Medicine Efficacy in Alzheimer′s Disease. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/2455800
Vancouver
Sun H, Huang D, Yang F, Zhang P, Yang D, Zeng C. Metabolomic Discoveries for Traditional Chinese Medicine Efficacy in Alzheimer′s Disease. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/2455800
BibTeX
@article{Sun2026,
author = {Sun, Huimin and Huang, Dongxuan and Yang, Fang and Zhang, Pengfei and Yang, Dexin and Zeng, Changchun},
title = {Metabolomic Discoveries for Traditional Chinese Medicine Efficacy in Alzheimer′s Disease},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/2455800}
}
EUVIMED